droxidopa has been researched along with Multiple System Atrophy Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, BP; Gupta, F | 1 |
| Biaggioni, I; Feirtag, M; Freeman, R; Hewitt, LA; Kaufmann, H; Low, P; Mathias, CJ; Mauney, J; Pedder, S | 1 |
| Isaacson, S; Kalu, U; Rowse, GJ; Vernino, S; White, WB; Ziemann, A | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Pechnik, S; Sewell, L | 1 |
| Kaufmann, H | 1 |
| Mathias, CJ | 1 |
| Freeman, R; Landsberg, L; Young, J | 1 |
| Aragishi, A; Braune, S; Keeling, JE; Mathias, CJ; Senard, JM; Taylor, MD; Watson, L | 1 |
2 review(s) available for droxidopa and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States | 2008 |
L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Autonomic Nervous System Diseases; Blood Pressure; Clinical Trials, Phase II as Topic; Dopa Decarboxylase; Droxidopa; Enzyme Inhibitors; Europe; Humans; Hypotension, Orthostatic; Multiple System Atrophy; Norepinephrine; Parkinson Disease | 2008 |
5 trial(s) available for droxidopa and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Topics: Aged; Autonomic Agents; Autonomic Nervous System Diseases; Blood Pressure; Dizziness; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Nervous System Diseases; Parkinson Disease; Posture; Pure Autonomic Failure; Time Factors; Treatment Outcome | 2014 |
Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Pressure; Droxidopa; Female; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Long Term Adverse Effects; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstrictor Agents; Young Adult | 2016 |
Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
Topics: Aged; Antiparkinson Agents; Blood Pressure; Carbidopa; Catechols; Double-Blind Method; Droxidopa; Drug Interactions; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nitriles; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstriction | 2011 |
The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Cross-Over Studies; Double-Blind Method; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Tilt-Table Test; Vascular Resistance | 1999 |
L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Dose-Response Relationship, Drug; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Norepinephrine | 2001 |
1 other study(ies) available for droxidopa and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
Topics: Accidental Falls; Aged, 80 and over; Antiparkinson Agents; Droxidopa; Female; Humans; Hypotension, Orthostatic; Midodrine; Multiple System Atrophy; Syncope; Treatment Outcome; Vasoconstrictor Agents | 2017 |